Mathieu J.F. Crupi

Mathieu J.F. Crupi

Ottawa University

H-index: 12

North America-United States

About Mathieu J.F. Crupi

Mathieu J.F. Crupi, With an exceptional h-index of 12 and a recent h-index of 12 (since 2020), a distinguished researcher at Ottawa University, specializes in the field of Cancer.

His recent articles reflect a diverse array of research interests and contributions to the field:

Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics

A role for the cell adhesion molecule NCAM1 in regulating activity of the receptor tyrosine kinase RET in cancer

Extracellular vesicles and viruses: two intertwined entities

Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies

Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy

Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus

AT cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection

Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment

Mathieu J.F. Crupi Information

University

Position

Ottawa Hospital Research Institute

Citations(all)

407

Citations(since 2020)

335

Cited By

167

hIndex(all)

12

hIndex(since 2020)

12

i10Index(all)

16

i10Index(since 2020)

14

Email

University Profile Page

Ottawa University

Google Scholar

View Google Scholar Profile

Mathieu J.F. Crupi Skills & Research Interests

Cancer

Top articles of Mathieu J.F. Crupi

Title

Journal

Author(s)

Publication Date

Loss of tumor suppressor TMEM127 drives RET-mediated transformation through disrupted membrane dynamics

eLife

Timothy J Walker

Eduardo Reyes-Alvarez

Brandy D Hyndman

Michael G Sugiyama

Larissa CB Oliveira

...

2024/4/30

A role for the cell adhesion molecule NCAM1 in regulating activity of the receptor tyrosine kinase RET in cancer

Cancer Research

Montdher H Hussain

Brandy D Hyndman

Frederick S Vizeacoumar

Mathieu J Crupi

Franco J Vizeacoumar

...

2024/3/22

Extracellular vesicles and viruses: two intertwined entities

Coline Moulin

Mathieu JF Crupi

Carolina S Ilkow

John C Bell

Stephen Boulton

2023/1/5

Synthetic virology approaches to improve the safety and efficacy of oncolytic virus therapies

Nature communications

Taha Azad

Reza Rezaei

Ragunath Singaravelu

Adrian Pelin

Stephen Boulton

...

2023/5/26

Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy

Pharmaceuticals

Nikolas T Martin

Mathieu JF Crupi

Zaid Taha

Joanna Poutou

Jack T Whelan

...

2023/5/7

Syngeneic mouse model of human HER2+ metastatic breast cancer for the evaluation of trastuzumab emtansine combined with oncolytic rhabdovirus

Frontiers in Immunology

Zaid Taha

Mathieu JF Crupi

Nouf Alluqmani

Faiha Fareez

Kristy Ng

...

2023/4/19

AT cell-targeted multi-antigen vaccine generates robust cellular and humoral immunity against SARS-CoV-2 infection

Molecular Therapy-Methods & Clinical Development

Stephen Boulton

Joanna Poutou

Rida Gill

Nouf Alluqmani

Xiaohong He

...

2023/12/14

Fatty acid transport protein inhibition sensitizes breast and ovarian cancers to oncolytic virus therapy via lipid modulation of the tumor microenvironment

Frontiers in Immunology

Abera Surendran

Monire Jamalkhah

Joanna Poutou

Rayanna Birtch

Christine Lawson

...

2023/3/10

Optimal delivery of RNA interference by viral vectors for cancer therapy

Boaz Wong

Rayanna Birtch

Reza Rezaei

Taylor Jamieson

Mathieu JF Crupi

...

2023/11/1

CRISPR-mediated rapid arming of poxvirus vectors enables facile generation of the novel immunotherapeutic STINGPOX

Frontiers in Immunology

Jack T Whelan

Ragunath Singaravelu

Fuan Wang

Adrian Pelin

Levi A Tamming

...

2023

Inhibition of exchange proteins directly activated by cAMP as a strategy for broad-spectrum antiviral development

Journal of Biological Chemistry

Stephen Boulton

Mathieu JF Crupi

Siddharth Singh

Madalina E Carter-Timofte

Taha Azad

...

2023/6/1

Virally programmed extracellular vesicles sensitize cancer cells to oncolytic virus and small molecule therapy

Nature communications

Marie-Eve Wedge

Victoria A Jennings

Mathieu JF Crupi

Joanna Poutou

Taylor Jamieson

...

2022/4/7

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer

Frontiers in Immunology

Mathieu JF Crupi

Zaid Taha

Thijs JA Janssen

Julia Petryk

Stephen Boulton

...

2022/11/3

Identification of FDA-approved bifonazole as a SARS-CoV-2 blocking agent following a bioreporter drug screen

Molecular Therapy

Zaid Taha

Rozanne Arulanandam

Glib Maznyi

Elena Godbout

Madalina E Carter-Timofte

...

2022/9/7

More than a ligand: PD-L1 promotes oncolytic virus infection via a metabolic shift that inhibits the type I interferon pathway

bioRxiv

Jonathan J Hodgins

John Abou-Hamad

Ash Hagerman

Edward Yakubovich

Christiano Tanese de Souza

...

2022/9/3

Single-dose replicating poxvirus vector-based RBD vaccine drives robust humoral and T cell immune response against SARS-CoV-2 infection

Molecular Therapy

Stephen Boulton

Joanna Poutou

Nikolas T Martin

Taha Azad

Ragunath Singaravelu

...

2022/5/4

Characterization of Critical Determinants of ACE2-RBD Interaction

Emily Brown

Reza Rezaei

Taylor Jamieson

Jaahnavi Dave

Nikolas Martin

...

2021

Luciferase-based biosensors in the era of the COVID-19 pandemic

Taha Azad

Helena J Janse van Rensburg

Jessica Morgan

Reza Rezaei

Mathieu JF Crupi

...

2021/8/9

Nanoluciferase complementation-based bioreporter reveals the importance of N-linked glycosylation of SARS-CoV-2 S for viral entry

Molecular Therapy

Taha Azad

Ragunath Singaravelu

Zaid Taha

Taylor R Jamieson

Stephen Boulton

...

2021/2/10

A high-throughput NanoBiT-based serological assay detects SARS-CoV-2 seroconversion

Nanomaterials

Taha Azad

Reza Rezaei

Ragunath Singaravelu

Taylor R Jamieson

Mathieu JF Crupi

...

2021/3/22

See List of Professors in Mathieu J.F. Crupi University(Ottawa University)